Related references
Note: Only part of the references are listed.IL-1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome
Kari Luotola et al.
CLINICAL ENDOCRINOLOGY (2016)
Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study
Meri-Maija E. Ollila et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Daniel A. Dumesic et al.
ENDOCRINE REVIEWS (2015)
Total Body Fat and Central Fat Mass Independently Predict Insulin Resistance but Not Hyperandrogenemia In Women With Polycystic Ovary Syndrome
Flavia Tosi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
HOMA and Matsuda indices of insulin sensitivity: poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings
A. H. Xiang et al.
DIABETOLOGIA (2014)
Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
Michael W. O'Reilly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Statin Therapy Worsens Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
Johanna Puurunen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Simvastatin Reduces Steroidogenesis by Inhibiting Cyp17a1 Gene Expression in Rat Ovarian Theca-Interstitial Cells
Israel Ortega et al.
BIOLOGY OF REPRODUCTION (2012)
Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial
Nazia Raja-Khan et al.
FERTILITY AND STERILITY (2011)
Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up
Miriam Hudecova et al.
FERTILITY AND STERILITY (2011)
Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, But Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance
Louise Manneras-Holm et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Cardiovascular Disease and Risk Factors in PCOS Women of Postmenopausal Age: A 21-Year Controlled Follow-Up Study
Johanna Schmidt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Effects of Simvastatin and Metformin on Polycystic Ovary Syndrome after Six Months of Treatment
Beata Banaszewska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes
K. Luotola et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes Whitehall II Prospective Cohort Study
Maren Carstensen et al.
DIABETES (2010)
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Robert A. Wild et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Statins Inhibit Growth of Human Theca-Interstitial Cells in PCOS and Non-PCOS Tissues Independently of Cholesterol Availability
Anna Sokalska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study
Cemil Kaya et al.
FERTILITY AND STERILITY (2009)
Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial
Beata Banaszewska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Effect of Atorvastatin in Patients with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Study
Thozhukat Sathyapalan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: Prospective, randomized, crossover trial
Beata Banaszewska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Abdominal obesity and metabolic syndrome
Jean-Pierre Despres et al.
NATURE (2006)
IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?
Stephane Perrier et al.
FEBS LETTERS (2006)
Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial
AJ Duleba et al.
FERTILITY AND STERILITY (2006)
Insulin sensitivity and β-cell function in women with polycystic ovary syndrome
J Vrbíková et al.
DIABETES CARE (2002)
Share Paper
